Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

ClinicalTrials.gov ID: NCT06417775

Public ClinicalTrials.gov record NCT06417775. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Ubrogepant for the Preventive Treatment of Menstrual Migraine With an Open-Label Extension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms. Menstrual migraine (MM) is defined as migraine attacks that occur within the perimenstrual period (PMP) in at least 2 out of 3 menstrual cycles. The PMP is from 2 days before the onset of menstrual bleeding to 2 days after. This study will assess how safe and effective ubrogepant is in treating menstrual migraine. Adverse Events and change in disease activity will be assessed. Ubrogepant is an investigational drug being developed for short-term prevention of menstrual migraine. Participants will be randomly assigned to one of the 2 groups to receive either ubrogepant or placebo. Around 496 adult female participants with menstrual migraine will be enrolled in approximately 100 sites in the United States and Puerto Rico. Participants will receive oral ubrogepant tablets once daily for 7 consecutive days starting 3 days prior to estimated onset of menses per cycle for 3 PMPs during double-blind period (16 weeks). Eligible participants may continue to receive oral ubrogepant tablets once daily for 7 consecutive days per cycle starting 3 days prior to estimated onset of menses during open-label extension period (52 weeks). There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will collect data daily in electronic diaries and attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

Study identification

NCT ID
NCT06417775
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
496 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 9, 2024
Primary completion
Oct 31, 2027
Completion
Oct 31, 2027
Last update posted
Aug 13, 2026

2024 – 2027

United States locations

U.S. sites
103
U.S. states
39
U.S. cities
95
Facility City State ZIP Site status
Central Research Associates /ID# 260161 Birmingham Alabama 35205
Rehabilitation and Neurological Services /ID# 275593 Huntsville Alabama 35805
MD First Research - Chandler /ID# 262564 Chandler Arizona 85286
Gilbert Neurology /ID# 260179 Gilbert Arizona 85297
Foothills Research Center/CCT Research /ID# 260180 Phoenix Arizona 85044
Trialmed-Synexus Clinical Research US, Inc. - Tucson /ID# 258309 Tucson Arizona 85741
Preferred Research Partners /ID# 262786 Little Rock Arkansas 72211
Preferred Research Partners /ID# 273128 Little Rock Arkansas 72211
Hope Clinical Research /ID# 257867 Canoga Park California 91303
Axiom Research /ID# 257833 Colton California 92324
Neuro Pain Research Center /ID# 257155 Fresno California 93710
Axiom Research, LLC-Los Angeles /ID# 264085 Glendale California 91206
Sun Valley Research Center /ID# 257152 Imperial California 92251-9401
Axiom Research - Irvine /ID# 264083 Irvine California 92604
CenExel Collaborative Neuroscience Research /ID# 257828 Los Alamitos California 90720
BNL Health - Los Angeles Headache Center /ID# 257237 Los Angeles California 90067-2001
M3 Wake Research - Newport Beach /ID# 257158 Newport Beach California 92660
Artemis Institute for Clinical Research - San Diego /ID# 257134 San Diego California 92103-2204
M3 Wake Research - Convoy /ID# 257897 San Diego California 92111
Optimus Medical /ID# 257856 San Francisco California 94102
New England Institute for Clinical Research /ID# 264019 Stamford Connecticut 06905
Neurology Offices of South Florida, PLLC /ID# 257161 Boca Raton Florida 33428-2231
Accel Research Sites Network - DeLand Clinical Research Unit /ID# 257403 DeLand Florida 32720
Accel Research Sites - Lakeland Clinical Research Unit /ID# 257874 Lakeland Florida 33803
Well Pharma Medical Research /ID# 257199 Miami Florida 33143
Indago Research and Health Center /ID# 277943 Miami Lakes Florida 33016
Sensible Healthcare /ID# 257198 Ocoee Florida 34761
Clinical Neuroscience Solutions, Inc /ID# 257190 Orlando Florida 32801-2986
Conquest Research /ID# 258314 Winter Park Florida 32789
NeuroTrials Research /ID# 274507 Atlanta Georgia 30328
Clinical Research Atlanta - Headlands LLC /ID# 260181 Stockbridge Georgia 30281-9054
Hawaii Pacific Neuroscience /ID# 274469 Honolulu Hawaii 96817
Velocity Clinical Research - Boise /ID# 257135 Meridian Idaho 83642
Healthcare Research Network /ID# 257868 Tinley Park Illinois 60477
Deaconess Midtown Hospital /ID# 257400 Evansville Indiana 47710
Accellacare - McFarland Clinic /ID# 257834 Ames Iowa 50010
Alliance for Multispecialty Research LLC /ID# 257839 Newton Kansas 67114
Collective Medical Research /ID# 257131 Overland Park Kansas 66210
Alliance For Multispeciality Research - Wichita East /ID# 257148 Wichita Kansas 67207
Tandem Clinical Research - Marrero - Barataria Boulevard /ID# 260146 Marrero Louisiana 70072
IMA Clinical Research Monroe - Wood /ID# 259362 Monroe Louisiana 71201
Headlands PharmaSite /ID# 257208 Baltimore Maryland 21208
Boston Clinical Trials /ID# 257132 Boston Massachusetts 02131-2515
BTC of New Bedford /ID# 257128 New Bedford Massachusetts 02740
MedVadis Research /ID# 257156 Waltham Massachusetts 02451
Michigan Headache & Neurological Institute (MHNI) /ID# 257179 Ann Arbor Michigan 48104-5131
Memorial Healthcare Institute For Neuroscience /ID# 274663 Owosso Michigan 48867
Proven Endpoints LLC /ID# 273796 Ridgeland Mississippi 39157
HealthCare Research Network - Hazelwood /ID# 257402 Hazelwood Missouri 63042
Clinvest Research LLC /ID# 257215 Springfield Missouri 65807
Methodist Physicians Clinic/CCT Research /ID# 260167 Fremont Nebraska 68025
Cognitive Clinical Trials (CCT) - Papillion /ID# 260174 Papillion Nebraska 68046-4131
IMA Clinical Research Las Vegas /ID# 258679 Las Vegas Nevada 89102-1955
M3 Wake Research-Las Vegas Rainbow /ID# 257895 Las Vegas Nevada 89118-2557
Bio Behavioral Health, Inc /ID# 257140 Toms River New Jersey 08755-6434
IMA Clinical Research Warren /ID# 263641 Warren Township New Jersey 07059
Albuquerque Clinical Trials, Inc. /ID# 257212 Albuquerque New Mexico 87102
Dent Neurologic Institute - Amherst /ID# 257219 Amherst New York 14226
IMA Clinical Research Westchester /ID# 259157 Hartsdale New York 10530
Fieve Clinical Research, Inc. /ID# 257177 New York New York 10017-1921
Rochester Clinical Research /ID# 257193 New York New York 14609
True North Neurology /ID# 274672 Port Jefferson Station New York 11776
Upstate Clinical Research Associates /ID# 257163 Williamsville New York 14221-6046
Headache Wellness Center /ID# 257136 Greensboro North Carolina 27405
Accellacare - South Hawthorne Road - Winston-Salem /ID# 257731 Winston-Salem North Carolina 27103
Accellacare - South Hawthorne Road - Winston-Salem /ID# 257850 Winston-Salem North Carolina 27103
Lillestol Research, LLC /ID# 257896 Fargo North Dakota 58104
CTI Clinical Research Center /ID# 257162 Cincinnati Ohio 45212-3784
C7 Research /ID# 272815 Cleveland Ohio 44109
Centricity Research Columbus /ID# 257221 Columbus Ohio 43213
Wright State Physicians Health Center /ID# 274708 Fairborn Ohio 45324
Lynn Institute of Oklahoma City /ID# 257857 Oklahoma City Oklahoma 73112
Central States Research /ID# 277867 Tulsa Oklahoma 74136
Summit Research Network - Portland - Northwest Vaughn Street /ID# 257139 Portland Oregon 97210
Abington Neurological Associates - Abington /ID# 257164 Abington Pennsylvania 19001
Clinical Research of Philadelphia, LLC /ID# 257197 Philadelphia Pennsylvania 19114
Partners In Clinical Research /ID# 257855 Cumberland Rhode Island 02864
Premier Neurology /ID# 260359 Greenville South Carolina 29605
Coastal Carolina Research Center - North Charleston /ID# 257227 North Charleston South Carolina 29405
WR-ClinSearch /ID# 257160 Chattanooga Tennessee 37421-1605
KCA Neurology /ID# 274495 Franklin Tennessee 37067
Alliance for Multispecialty Research - Knoxville /ID# 257846 Knoxville Tennessee 37920
FutureSearch Trials of Neurology /ID# 257186 Austin Texas 78731
FutureSearch Trials of Dallas, LP /ID# 257142 Dallas Texas 75231
Elevate Clinical - Seabrook /ID# 274679 Houston Texas 77058
Houston Clinical Research Associates /ID# 272077 Houston Texas 77090
Red Star Research, LLC /ID# 257871 Lake Jackson Texas 77566
Radiance Clinical Research /ID# 271727 Lampasas Texas 76550
Epic Clinical Research - Lewisville /ID# 274480 Lewisville Texas 75057
Sms Clinical Research /ID# 278443 Mesquite Texas 75149
Clinpoint Trials /ID# 274524 Waxahachie Texas 75165
Foothill Family Draper Clinic /ID# 277876 Draper Utah 84020
Advanced Research Institute /ID# 257853 Ogden Utah 84405
J. Lewis Research - Salt Lake City - Foothill Drive /ID# 277877 Salt Lake City Utah 84109
J. Lewis Research, Inc. / Foothill Family Clinic South /ID# 258305 Salt Lake City Utah 84121-6923
Highland Clinical Research /ID# 257137 Salt Lake City Utah 84124
Charlottesville Medical Research /ID# 257154 Charlottesville Virginia 22911
Alliance for Multispecialty Research - Clinical Research Associates /ID# 257851 Norfolk Virginia 23502
Northwest Clinical Research Center /ID# 257381 Bellevue Washington 98007
Puget Sound Neurology /ID# 257174 Tacoma Washington 25328
Vaught Neurological Services /ID# 267519 Beckley West Virginia 25801
West Virginia Univ School Med /ID# 258898 Morgantown West Virginia 26506
Mind+ Neurology /ID# 274486 Mequon Wisconsin 53092

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06417775, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 13, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06417775 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →